Navigation Links
Northern Fertility & Reproductive Associates Adds Two Local Infertility Specialists to Staff, Opens New Offices In Center City And Blue Bell
Date:11/7/2007

PHILADELPHIA, Nov. 7 /PRNewswire/ -- Northern Fertility and Reproductive Associates is pleased to announce the addition of two, local board certified infertility specialists to the staff. Drs. Benjamin Gocial and Jacqueline Gutmann have joined Drs. Martin Freedman and Arthur Castelbaum, and are experienced, respected reproductive endocrinologists dedicated to the highest levels of personalized patient care and clinical excellence.

"We are delighted to have Drs. Gutmann and Gocial join our team, as they bring a compassionate, experienced approach to patient care," said Dr. Freedman. "Both of these respected physicians have been working with infertility patients in the Delaware Valley for decades and have helped thousands of hopeful women and men become parents."

Dr. Gutmann is a Clinical Associate Professor and Associate Director, Division of Reproductive Endocrinology and Infertility at Thomas Jefferson University School of Medicine. Named a "Top Doc" in Philadelphia, Dr. Gutmann specializes in the assisted reproductive technologies, polycystic ovarian syndrome (PCOS), third party reproduction and family building for same sex couples, and has a strong interest in complementary medicine.

Dr. Gocial is a Clinical Assistant Professor of Obstetrics and Gynecology at Thomas Jefferson University School of Medicine. Also named a "Top Doc" in Philadelphia, he has extensive experience in reproductive medicine, with particular expertise in minimally invasive surgical techniques and is internationally recognized as a leading laparoscopic surgeon.

"One in eight couples in the greater Philadelphia area is affected by infertility and require medical care to help them have a baby. Our new offices in Center City and Blue Bell were designed specifically with the needs of our patients in mind, ensuring a comfortable, private and convenient environment and state-of-the-art medical facilities to deliver the most effective infertility treatments available,
'/>"/>

SOURCE Northern Fertility and Reproductive Associates
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Northern Michigan Regional Health System Named a Working Mother 100 Best Company - 2007 by Working Mother Magazine
2. Unions File Charges Against Tenet Healthcare Corporation, Three Northern California Hospitals
3. Angel Flight West Recognizes Northern California Pilots at AFW 24th Anniversary Awards
4. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
5. Dont just save her life, save her fertility
6. OHSU is part of national effort to preserve, restore fertility in women with cancer
7. World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress
8. Bay IVF Experts Launch One of First East-West Fertility Programs of Its Kind
9. UVA researchers find important clue to immune infertility
10. Gene Mutation Key to Infertility in Male Mice
11. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Assembly Member Tom Torlakson Introduces AB 89 , ...ire/ -- Today, Lung Cancer Alliance-California (...lakson (D-11th District) for his continued leaders...or lung cancer research. For the third consecutiv...search is being considered in the California Legis...
(Date:1/8/2009)...pts Prenatal Solution Key Factor in Decision for F...RLANDO, Fla., Jan. 8 All...LLC, one of the largest multi-specialty group prac... the Allscripts Enterprise(TM) Electronic Health R...cians in 18 offices across Central Florida. , ...
(Date:1/8/2009)... St. Jude Children,s Research Hospital have demons...eumonia following influenza. They found that the a...l bacteria by inhibiting their protein synthesis, ...tment with the "beta-lactam" antibiotic ampicillin..., The finding is important because pneumonia, rat...
(Date:1/8/2009)..., Jan. 8 Allscripts-Misy... Healthcare Solutions, Inc. (Allscripts or,the Co...the three and six,months ended November 30, 2008....rnh/20061005/ALLSCRIPTSLOGO-b ) , The Compa...vember 30, 2008,include results from legacy Allsc...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13
... from Wake Forest University School of Medicine ha...lar// that reducing injury to the aorta which may... the development of complications to the heart whi... feel by following a technique which reduces injur...
...istwatch invented by South Africa's Gervan Lubbe w...t to be a health hazard. They have warned that the...s diseases like HIV/AIDS.// There are some who hav...an really perform functions like detecting disease...
...y four Marlboro smokers for hi-tech screenings aim... people are demanding that the company pay for spi... were to be brought into force, it will serve to s...etection. The company has been accused of indulgin...
...versity of New South Wales scientists resulted in ...ment can be life threatening and resulted in early...gh because //they identified that the patients who...ffer a progression of the disease, compared with t...
Other Medicine News:Health News:Breaks In The HIV Treatment Resulted In Devastating Results. 2
(Date:1/8/2009)...e in an ongoing Phase Ib trial demonstrated a 2.5 ..., , Conference Call Today at 8:30AM EST , , ... Pharmaceuticals, Inc. (Nasdaq: ANDS ) today ann... Phase Ib clinical trial of ANA598, the Company,s ...r. ANA598 was very well-tolerated and demonstrate...
(Date:1/7/2009)...ease , , WHITE PLAINS, N.Y., Jan. 7 /PRNewswire...that the decades-long rise in the United States pr...han ever at increased risk of death and disability...3,000 babies were born too soon in 2006, according...ch today released "Births: Final data for 2006," N...
(Date:1/7/2009)...ntan Puhua Hospital Stem Cells Center ( http://www...ng stem cells to effectively treat neurological di...ced additions to its medical and research staff th...apabilities for growing numbers of incoming intern...he distinguished Dr. Jiang Ping, who was named Chi...
(Date:1/6/2009)...ntaining a healthy immune system , , PURCHASE, ...study in Nutrition and Cancer (60(5), 643-651) b...a, Japan has shown that AHCC (Active Hexose Correl...ing the number of dendritic cells (DCs). DCs are a...senting foreign substances to other immune system ...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Preterm Births Rise 36 Percent Since Early 1980s 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Delayed angioplasty big bucks no bang 5485 1Delayed angioplasty big bucks no bang 5485 2Genelabs Technologies to Present at the Acumen Biofin Rodman 26 Renshaw 9th Annual Healthcare Conference 5482 1Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 1Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 2Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 3Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 4Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 5Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 6Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 7Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 1Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 2Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 3
...7 /PRNewswire-FirstCall/ -- Vanda,Pharmaceuticals ...f,the Henry Ford Sleep Disorders and Research Cent...on on recent Phase III clinical,trial results for ...ptor agonist, at SLEEP 2007, the 21st annual meeti... (APSS). , The Vanda presentation will take place ...
...IRE)--Jun 8, 2007 - Archemix Corp., a,biotechnolog...tamers, announced the successful completion of a P...1779. ARC1779 is designed to,selectively block the... by inhibiting the binding of von Willebrand Facto...ed vWF is scientifically,recognized as the first s...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3
... knee prosthesis stems from many years of experien... and manufacturing technologies have been used in ... well as a favorable pressure distribution pattern... a minimum. The inherent design of the components,...
... "Consensus Concept" approach to design by combini...perience of a Scientific Advisory Board. The resul...tate-of-the-art features. Consensus Knee implants ...bility and allow near normal kinematics. The compo...
The major innovations in posterior stabilized (PS) knee design.
The GENESIS II* Total Knee System will define the state of knee implants.
Medicine Products: